Raxone for Leber's hereditary optic neuropathy (LHON)
Quick answer: Raxone is used for Leber's hereditary optic neuropathy (LHON) as part of a synthetic benzoquinone (mitochondrial electron transfer agent) treatment regimen. Short-chain benzoquinone that transfers electrons directly to complex III of the mitochondrial electron transport chain, bypassing complex I dysfunction The specific dosing for Leber's hereditary optic neuropathy (LHON) is determined by your prescriber based on individual factors.
Why is Raxone used for Leber's hereditary optic neuropathy (LHON)?
Raxone belongs to the Synthetic benzoquinone (mitochondrial electron transfer agent) class. Short-chain benzoquinone that transfers electrons directly to complex III of the mitochondrial electron transport chain, bypassing complex I dysfunction This action makes it useful for treating or managing Leber's hereditary optic neuropathy (LHON) in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Raxone is the right choice for a specific patient depends on the type and severity of Leber's hereditary optic neuropathy (LHON), response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for Leber's hereditary optic neuropathy (LHON)
Common adult dosing range: 300 mg three times daily. The actual dose for Leber's hereditary optic neuropathy (LHON) depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Raxone medicine page.
What to expect
Raxone treatment for Leber's hereditary optic neuropathy (LHON) typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on Leber's hereditary optic neuropathy (LHON)
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Raxone is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Synthetic benzoquinone (mitochondrial electron transfer agent) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Raxone
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Raxone full prescribing information · All Synthetic benzoquinone (mitochondrial electron transfer agent) alternatives
Frequently asked questions
How effective is Raxone for Leber's hereditary optic neuropathy (LHON)?
Effectiveness varies by individual response, dose, and severity. Raxone is one of several treatment options for Leber's hereditary optic neuropathy (LHON), supported by clinical evidence within the synthetic benzoquinone (mitochondrial electron transfer agent) class. Discuss expected response with your prescriber.
How long do I need to take Raxone for Leber's hereditary optic neuropathy (LHON)?
Treatment duration depends on the nature of Leber's hereditary optic neuropathy (LHON) — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Raxone when used for Leber's hereditary optic neuropathy (LHON)?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Raxone for Leber's hereditary optic neuropathy (LHON)?
Yes. Multiple medicines and non-drug options exist for Leber's hereditary optic neuropathy (LHON). Alternatives within the synthetic benzoquinone (mitochondrial electron transfer agent) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.